Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
 
Advanced search:
Enter Search Keyword
 
Filter your search by:
Country
Publisher
Publish date
Search By Price Range
From:$
    To:$
 
To receive alerts for latest Pharma & Healthcare reports, signup here.
Email ID
 
Pharma & Healthcare | Pharmaceuticals | Diseases and Conditions
Results 1-10 of 15  1 2 >  Sort By :
Title Date Price
Frontier Pharma: Obesity Identifying and Commercializing First-in-Class Innovation
By GBI Research
Despite the market's clinical and regulatory challenges, the obesity pipeline is robust and contains a high level of diversity in both molecule types and molecular targets, which is in line with its m ...Read More
Oct 2015 $6995.00
Opportunity Analyzer: Celiac Disease - Opportunity Analysis and Forecast to 2018
By GlobalData
There are no pharmacological treatments that are indicated for celiac disease and the current standard of care treatment involves a gluten free diet (GFD). Steroids and immunosuppressants are used to ...Read More
Nov 2014 $7995.00
Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries
By GBI Research
Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries’ report provides insights into M ...Read More
Oct 2014 $4995.00
Asthma - Global Drug Forecast and Market Analysis to 2023
By GlobalData
Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over th ...Read More
Aug 2014 $10995.00
Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2023
By GlobalData
GlobalData estimates that the total market size for the 7MM in 2013 was $12.3bn, comprised of $5.0bn in branded drug sales (40%) and $7.3bn in generic sales (60%). GlobalData expects that the ACS drug ...Read More
Aug 2014 $10995.00
OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) ? Opportunity Analysis and Forecasts to 2017 - Event-Driven Update
By GlobalData
The NASH market is currently deserted and awaits its first NASH-specific therapy. With novel mechanism of action awaiting approval such as: Genfit’s PPAR agonist, GFT505 and Intercept Pharmaceut ...Read More
Mar 2014 $5995.00
PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022
By GlobalData
Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural instability. As the second most common neurodegenerative disorder, P ...Read More
Mar 2014 $10995.00
OpportunityAnalyzer: Pancreatic Cancer Opportunity Analysis and Forecasts to 2017
By GlobalData
With five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some of the highest unmet need in oncology. This report focuses on the current treatment landscape, ...Read More
Mar 2014 $5995.00
OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecasts to 2017
By GlobalData
Endometriosis is a gynecological disorder affecting women of childbearing age. This inflammatory condition is characterized by the growth of endometrial tissues outside of the uterus, and can cause ch ...Read More
Feb 2014 $7995.00
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022
By GlobalData
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion ...Read More
Feb 2014 $10995.00
Results 1-10 of 15  1 2 > 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z